Health technology reviews

" "

Glucose monitoring

Continuous glucose monitoring (CGM) was first reviewed by the HTA program in 2011.

  • In 2017, the HCA director selected glucose monitoring for re-review based on newly available published evidence.
  • A re-review of glucose monitoring was conducted in 2018.

Status: Decision completed.

View final findings and decision

Policy context

Glucose monitoring (CGM) was proposed for re-review based on new evidence and expanded indications for use. 

Primary criteria ranking

  • Safety = Medium
  • Efficacy = High
  • Cost = High

Assessment timeline (2018)

  • ​Draft key questions published: August 16, 2017
  • Public comment period: August 16 to 29, 2017
  • Final key questions published: September 14, 2017
  • Draft report published: November 9, 2017
  • Public comment period: November 9 to December 8, 2017
  • Final report published: December 29, 2017
  • HTCC public meeting: January 19, 2018